McRaeD.Early History of Heart Transplantation: ISHLT Monograph Series. Vol 4. Philadelphia, PA: Elsevier; 2010;1:1–36.
2.
YoungJBBaumgartnerWAReitzBAOhlerL.History of Heart Transplantation: ISHLT Monograph Series. Vol 4. Philadelphia, PA: Elsevier; 2010:45–90. Chap 3.
3.
FontanFKirklinJWGernandezG. Outcome after a “perfect” Fontan operation. Circulation. 1990;81(5):1520–1536.
4.
de LevalMRKilnerPGewilligMBullC. Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations experimental studies and early clinical experience. J Thorac Cardivasc Surg. 1988;96(5):682–695.
5.
DabalRJKirklinJKKukrejaM. The modern Fontan operation shows no increase in mortality out to 20 years: a new paradigm. J Thorac Cardiovasc Surg. 2014;148(6):2517–2523.
6.
RychikJFogelMADonofrioMT. Comparison of patterns of pulmonary venous blood flow in the functional single ventricle heart after operative aortopulmonary shunt versus superior cavopulmonary shunt. Am J Cardiol. 1997;80(7):922–926.
7.
PennyDJRedingtonAN. Diastolic ventricular function after the Fontan opearation. Am J Cardiolo. 1992;69(9):974–975.
8.
GewilligMBrownSCEyskensB. The Fontan circulation: who controls cardiac output?. Interact Cardiovasc Thorac Surg. 2010;10(3):428–433.
9.
ParidonSMMitchellPDColanSD. A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol. 2008;52(2):99–107.
10.
LambertEd’UdekemYCheungM. Sympathetic and vascular dysfunction in adult patients with Fontan circulation. Int J Cardiol. 2013;167(4):1333–1338.
11.
HaworthSGReidL. Quantitative structural study of pulmonary circulation in the newborn with aortic atresia, stenosis, or coarctation. Thorax. 1977;32(2):121–128.
12.
RychikJ. Protein-losing enteropathy after Fontan operation. Congenit Heart Dis. 2007;2(5):288–300.
13.
MertensLHaglerDJSauerUSomervilleJGewilligM. Protein-losing enteropathy after the Fontan operation: an international multi-center study. PLE study group. J Thorac Cardiovasc Surg. 1998;115(5):1063–1073.
14.
MeadowsJJenkinsK. Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment. Cardiol Young. 2011;21(4):363–377.
15.
GriffithsERKazaAKWyler von BallmoosMC. Evaluating failing Fontans for heart transplantation: predictors of death. Ann Thorac Surg. 2009;88(2):558–564.
16.
DoriYKellerMSRychikJItkinM. Successful treatment of plastic bronchitis by selective lymphatic embolization in a Fontan patient. Pediatrics. 2014;134(2):e590–e595.
17.
DaviesRRSorabellaRAYangJMoscaRSChenJMQuaegebeurJM. Outcomes after transplantation for “failed” Fontan: a single-institution experience. J Thorac Cardiovasc Surg. 2012;143(5):1183–1192
18.
RychikJ. The relentless effects of the Fontan Paradox. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2016;19(1):37–43.
19.
RychikJVeldtmanGRandE. The precarious state of the liver after a Fontan operation: summary of a multi-disciplinary symposium. Pediatr Cardiol. 2012;33(7):1001–1012.
20.
SimpsonKEEsmaeeliAKhannaG. Liver cirrhosis in Fontan patients does not affect 1-year post heart liver mortality or markers of liver function. J Heart Lung Transplant. 2014;33(2):170–177.
21.
YooBWChoiJYEunLYParkHKParkYWKimSU. Congestive hepatopathy after Fontan operation and related factors assessed by transient elastography. J Thorac Cardiovsc Surg. 2014;148(4):1498–1505.
22.
WuFMOpotowskyARRazaR. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis. Congenit Heart Dis. 2014;9(5):438–447.
23.
O’ConnorMJLindCTangX. Persistence of antihuman leukocyte antibodies in congenital heart disease late after surgery using allografts and whole blood. J Heart Lung Transplant. 2013;32(4):390–397.
24.
CastleberryCRyanTDChinC. Transplantation in the highly sensitized pediatric patient. Circulation. 2014;129(22): 2313–2319.
25.
ChinCChenGSequeriaF. Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant. 2011;30(2):158–163.
26.
Pollock-BarZivSMden HollanderNNganBY. Pediatric heart transplantation in human leukocyte antigen sensitized patients. Circulation. 2007;116(suppl 11):i172–i178.
27.
BernsteinDNaftelDChinC. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006;114(4):273–280.
28.
KovachJRNaftelDCPearceFB. Comparison of risk factors and outcomes for pediatric patients listed for heart transplantation after bidirectional Glenn and after Fontan: an analysis from the pediatric heart transplant study. J Heart Lung Transplant. 2012;31(2):133–139.
29.
MauchleyDCMitchellMB. Transplantation in the Fontan patient. Semin Thorac Cardiovasc Surg Pediatr Card Surg Ann. 2015;18(1):7–16.
30.
LamourJMKanterKRNaftelDC. Surgery in children and adults undergoing heart transplantation for congenital heart disease. J Am Coll Cardiol. 2009;54(2):160–165.
31.
DipchandAIRossanoJWEdwardsLB. The registry of the international society for heart and lung transplantation: eighteenth official pediatric heart transplantation report-2015; focus theme: early graft failure. the journal of heart and lung transplantation: the official publication of the international society for heart transplantation. J Heart Lung Transplant. 2015;34(10):1233–1243
32.
SimpsonKEPruittEKirklinJK. Fontan patient survival after pediatric heart transplantation has improved in the current era. Ann Thorac Surg. 2017;103(4):1315–1320.
33.
MillerJRSimpsonKEEpsteinDJ. Improved survival after heart transplant for failed Fontan patients with preserved ventricular function. J Heart Lung Transplant. 2016;35(7):877–883.
34.
KanterKR.Heart transplantation in children after a Fontan procedure: better than people think. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2016;19(1):44–49.
35.
ShiWYYongMSMcGiffinDC. Heart transplantation in Fontan patients across Australia and New Zealand. Heart. 2016;102(14):1120–1126.
36.
SchumacherKRGossettJGuleserianK. Fontan-associated protein-losing enteropathy and heart transplant: a pediatric heart transplant study analysis. J Heart Lung Transplant. 2015;34(9):1169–1176.
37.
BackerCLRussellHMPahlE. Heart transplantation for the failing Fontan. Ann Thorac Surg. 2013;96(4):1413–1419.
38.
GossettJGAlmondCSKirkR. Outcomes of cardiac transplantation in single-ventricle patients with plastic bronchitis: a multicenter study. J Am Coll Cardiol. 2013;61(9):985–986.